LongEWJun 2026
Edwards Lifesciences Corporation
Baron initiated Edwards Lifesciences because of its leadership in transcatheter aortic valve replacement and its emerging mitral and tricuspid valve therapies. The team believes…
EW
Which hedge funds are long EW?
2 published ideas on Edwards Lifesciences Corporation across 2 funds — 2 long and 0 short.
Each entry below comes from a hedge fund's own investor letter, not a 13F filing, so it carries the reasoning behind the position on Edwards Lifesciences Corporation: the full thesis, the risks the manager flagged, the conviction level and the time horizon. Positions may have changed since the letter was written.
Funds with a position view
Long theses
LongEWJun 2026
Edwards Lifesciences Corporation
Edwards Lifesciences is a leader in structural-heart therapies and has established its Sapien platform as a leading transcatheter aortic valve replacement system. Aristotle…